Certolizumab Pegol for the Treatment of Crohn’s Disease

Therapeutic Advances in Gastroenterology - United Kingdom
doi 10.1177/1756283x11413315
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Certolizumab Pegol in the Treatment of Axial Spondyloarthritis

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2015English

CERTOLIZUMAB PEGOL IN CHOHN'S DISEASE (Review)

Koloproktologia
2016English

Randomised Clinical Trial: Certolizumab Pegol for Fistulas in Crohn’s Disease - Subgroup Results From a Placebo-Controlled Study

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2010English

Evaluation of Mucosal Healing in Small Bowel Crohn’s Disease Treated With Certolizumab Pegol Assessed by Wireless Capsule Endoscopy

Clinical Case Reports and Reviews
2016English

Certolizumab Pegol in the Treatment of Takayasu Arteritis: The First Experience and Prospects

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2018English

Cost-Minimization and Budget Impact Analysis of Certolizumab Pegol for Patients With Crohn’s Disease, Moderate or Severe, With Relapse After Conventional Treatment From the Perspective of the Brazilian Private Payer

Jornal Brasileiro de Economia da Saúde
2017English

Photoallergic Drug Eruption Caused by Certolizumab Pegol

Acta Dermato-Venereologica
DermatologyMedicine
2016English

The Efficacy of Certolizumab Pegol Re-Treatment on Plaque Psoriasis Following a Blinded Treatment Break: Results From the CIMPACT Trial

SKIN The Journal of Cutaneous Medicine
2019English

Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis in Romania

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy